Testolone
Also known as: RAD-140, RAD140, Vosilasarm, EP0062
Classification
Sarm
Regulatory Status
not-established
Sources
3
Review
n/a
Overview
Testolone (RAD-140, vosilasarm) is a nonsteroidal selective androgen receptor modulator (SARM) that acts as an androgen receptor agonist; investigational oncology programs exploit AR activity in defined breast-cancer contexts, which is distinct from bodybuilding marketing claims.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Interactions & cautions
Flagged in source data
testosterone or anabolic steroids without review
Drug interactions
androgens or anabolic steroids — Additive androgenic/anabolic and hepatotoxicity concerns possible (review)
other hepatotoxic agents or supplements — May increase likelihood or severity of liver injury (review)
These are observational flags for review, not individualized instructions.
Sources
- https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/warrior-labz-sarms-655280-06122023 (opens in a new tab)
- https://www.fda.gov/drugs/medication-health-fraud/selective-androgen-receptor-modulators-sarms (opens in a new tab)
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10054042 (opens in a new tab)
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw